Rho GTP酶结合蛋白2基因表达与卵巢癌的预后关系及机制分析(3)
[3] Chen W，Zheng R，Baade P D，et al.Cancer statistics in China，2015[J].CA Cancer J Clin，2016，66(2)：115-132.
[4] Chen C，Guo Q，Shi J，et al.Genetic variants of MGMT，RHPN2，and FAM49A contributed to susceptibility of nonsyndromic orofacial clefts in a Chinese population[J].J Oral Pathol Med，2018，47(8)：796-801.
[5] Gyorffy B，Lanczky A，Szallasi Z.Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients[J].Endocr Relat Cancer，2012，19(2)：197-208.
[6] Peck J W，Oberst M，Bouker K B，et al.The RhoA-binding protein，rhophilin-2，regulates actin cytoskeleton organization[J].J Biol Chem，2002，277(46)：43924-43932.
[7] Danussi C，Akavia U D，Niola F，et al.RHPN2 drives mesenchymal transformation in malignant glioma by triggering RhoA activation[J].Cancer Res，2013，73(16)：5140-5150.
[8] Lee H K，Choung H W，Yang Y I，et al.ODAM inhibits RhoA-dependent invasion in breast cancer[J].Cell Biochem Funct，2015，33(7)：451-461.
[9] Robles A I，Traverso G，Zhang M，et al.Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers[J].Gastroenterology，2016，150(4)：931-943.
[10]何嘉曦.RHPN2通過调控Notch通路在肺腺癌中促进肿瘤生成[D].广州：广州医科大学，2016.
[11]蔡圣芸.卵巢癌预后相关新基因的鉴定及其功能研究[D].上海：第二军医大学，2016.
[12] Barger C J，Zhang W，Sharma A，et al.Expression of the POTE gene family in human ovarian cancer[J].Sci Rep，2018，8(1)：17136.
(收稿日期：2019-02-26) (本文编辑：郎序莹), http://www.100md.com(黄丹 周航 郑建清)
[4] Chen C，Guo Q，Shi J，et al.Genetic variants of MGMT，RHPN2，and FAM49A contributed to susceptibility of nonsyndromic orofacial clefts in a Chinese population[J].J Oral Pathol Med，2018，47(8)：796-801.
[5] Gyorffy B，Lanczky A，Szallasi Z.Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients[J].Endocr Relat Cancer，2012，19(2)：197-208.
[6] Peck J W，Oberst M，Bouker K B，et al.The RhoA-binding protein，rhophilin-2，regulates actin cytoskeleton organization[J].J Biol Chem，2002，277(46)：43924-43932.
[7] Danussi C，Akavia U D，Niola F，et al.RHPN2 drives mesenchymal transformation in malignant glioma by triggering RhoA activation[J].Cancer Res，2013，73(16)：5140-5150.
[8] Lee H K，Choung H W，Yang Y I，et al.ODAM inhibits RhoA-dependent invasion in breast cancer[J].Cell Biochem Funct，2015，33(7)：451-461.
[9] Robles A I，Traverso G，Zhang M，et al.Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers[J].Gastroenterology，2016，150(4)：931-943.
[10]何嘉曦.RHPN2通過调控Notch通路在肺腺癌中促进肿瘤生成[D].广州：广州医科大学，2016.
[11]蔡圣芸.卵巢癌预后相关新基因的鉴定及其功能研究[D].上海：第二军医大学，2016.
[12] Barger C J，Zhang W，Sharma A，et al.Expression of the POTE gene family in human ovarian cancer[J].Sci Rep，2018，8(1)：17136.
(收稿日期：2019-02-26) (本文编辑：郎序莹), http://www.100md.com(黄丹 周航 郑建清)